title: Facial tuberculoid leprosy: case report.
abstract: Leprosy is a chronic, infectious, systemic disease caused by Mycobacterium leprae and is classified as paucibacillary and multibacillary types. It is contagious and has an insidious onset. Clinical presentation is characterised by hypopigmented skin lesions with reduced sensation. Presence of acid-fast bacilli in tissue specimens is regarded as a gold standard for diagnosis. Treatment is based on multi-drug regimens. We report a case of borderline tuberculoid leprosy in a 31-year-old woman.
authors.affiliation: Department of Oral & Maxillofacial Surgery, The Great Western Hospital Swindon, SN3 6BB, UK. drkamranali@hotmail.com
authors.forename: K
authors.initials: K
authors.lastname: Ali
authors.forename: G
authors.initials: G
authors.lastname: Sittampalam
authors.forename: M A
authors.initials: MA
authors.lastname: Malik
mesh_terms: D000328:Adult; D002481:Cellulitis / Q000175:diagnosis; D003622:Dapsone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000382:microbiology*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D015439:Leprosy, Borderline / Q000175:diagnosis; D015441:Leprosy, Tuberculoid / Q000175:diagnosis*; D009166:Mycobacterium leprae / Q000302:isolation & purification; D011239:Prednisolone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D007917:Leprostatic Agents; D003622:Dapsone; D011239:Prednisolone; D012293:Rifampin